Compare Essex Property Trust, Inc. (ESS) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Essex Property Trust, Inc. vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Essex Property Trust, Inc. trades at $268.84 (market cap $17.47B), while GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Essex Property Trust, Inc. pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| ESS | GEHC | |
|---|---|---|
Market Cap | $17.47B | $31.07B |
Volume | 425,157 | 3,443,020 |
Sector | Real Estate | Health |
52-Week High | $298.33 | $88.16 |
52-Week Low | $239.61 | $59.48 |
Typical Hold Time | 112 Days | — |
Enterprise Value | $24.07B | $39.53B |
Dividend Yield | 3.81% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESS trades at $269.37, down 0.38% with neutral technical signals. The company shows strong profitability with 67.9% gross margins and 21.48% net income, though recent earnings were mixed with Q2 2026 missing expectations. Revenue growth has been steady, reaching $1.89B in 2025. Analyst consensus is mixed with 38.3% buy ratings and a $300.77 price target, representing 11.7% upside. Recent news highlights strong Q2 results and legal resolution.
ESS offers solid fundamentals with premium valuation (P/E 42.35) and strong operational efficiency. Key risks include earnings volatility and high debt levels ($6.46B long-term). The stock presents opportunity from raised guidance and institutional interest, but requires monitoring of West Coast real estate market conditions and interest rate sensitivity.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
